Mode
Text Size
Log in / Sign up

Mental health screening tools show varying diagnostic accuracy for adolescent depression in sub-Saharan AfricaScreening Tools Help Identify Depression in African Adolescents

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that 60% of studies regarding mental health screening tools in this region were at high risk of bias.

This systematic review and meta-analysis evaluated the diagnostic accuracy of mental health screening tools for adolescents aged 12 to 18 years in sub-Saharan Africa. The systematic review included 128 studies covering 26 different mental health disorders, while the meta-analysis focused on 36 articles evaluating four specific tools: EPDS, PHQ-9 (including two-step versions), PHQ-2, and K-10.

The authors noted that 60% (77/128) of studies in the systematic review were rated as high risk of bias on at least one QUADAS-2 domain. While Deeks' test and funnel plot assessments did not suggest publication bias for EPDS or PHQ-9, heterogeneity was present across validation studies for all tools included in the meta-analysis.

A significant limitation noted is that only 21 of 48 sub-Saharan African countries had validated at least one screening tool. The findings highlight a critical need for context-specific, validated mental health screening tools tailored specifically to adolescents in this region.

How this fits prior evidence

This meta-analysis addresses a gap in the availability of validated diagnostic tools for adolescent populations in specific geographic regions. While previous evidence has explored non-pharmacological interventions like dance and Tai Chi for depression or pharmacological options like esketamine for postoperative anxiety, this study focuses specifically on the accuracy of screening instruments (EPDS, PHQ-9, PHQ-2, K-10) to identify mental health disorders in adolescents within sub-Saharan Africa.

Researchers reviewed 128 studies to evaluate how well different tools identify mental health disorders in adolescents aged 12 to 18 in sub-Saharan Africa. The review covered 26 different conditions. A smaller group of 36 articles specifically looked at four common screening tools for depression: the EPDS, PHQ-9 (including two-step versions), PHQ-2, and K-10.

The results show that these tools are used to measure diagnostic accuracy. However, the researchers noted that many of the original studies had a high risk of bias. Additionally, only 21 out of 48 countries in the region had validated at least one screening tool for their specific population.

Because of the variety in how these tests were performed and the limited number of validated tools, the results should be viewed with caution. The findings highlight a significant need for more local, context-specific tools designed specifically for adolescents in this region to ensure accurate care.

What this means for you:
Several screening tools can identify depression in African youth, but many require more local validation.

Common questions

What specific tools were used to screen for depression?

The meta-analysis focused on four specific tools: the Edinburgh Postnatal Depression Scale (EPDS), Patient Health Questionnaire-9 (PHQ-9) and its two-step versions, the two-item PHQ (PHQ-2), and the Kessler Psychological Distress Scale (K-10).

How reliable are these screening tools for adolescents?

While these tools are used to identify depression, 60% of the studies reviewed were rated as having a high risk of bias. Additionally, only 21 out of 48 countries in sub-Saharan Africa had validated at least one tool.

Who is the target population for these screenings?

The study specifically looked at adolescents between the ages of 12 and 18 living in sub-Saharan Africa. The broader review covered 26 different mental health disorders among this age group.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
IntroductionMental health disorders (MHDs) is a global public health concern. Existing evidence highlighted the need for context-specific measurements of MHDs among adolescents in sub-Saharan Africa (SSA). This review aimed to provide an evidence-based inventory of effective mental health (MH) screening tools applicable to adolescents in SSA aged 12–18 years.MethodsWe systematically searched Medline, Web of Science Core Collection, PsycINFO, and CINAHL for validation studies of MH screening tools published between January 1, 2000 and December 31, 2024. Pooled sensitivity and specificity were estimated using hierarchical summary receiver operating characteristic (HSROC) models. Study quality was assessed using the Quality of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. Heterogeneity was evaluated using I² statistic and forest plots, while funnel plots and Deeks’ funnel plot asymmetry test were used to assess publication bias. The analyses were conducted in R 4.5.3 version.ResultsOut of the 18,918 screened articles, 128 studies (covering 26 MHDs) were included in the systematic review. Of these, 60% (77/128) were rated high risk of bias on at least one domain of the QUADAS-2 tool. Only 21 of 48 SSA countries validated at least one screening tool. The meta-analysis included 36 articles evaluating four tools—Edinburg Postnatal Depression Scale (EPDS), Patient Health Questionnaire-9 (PHQ-9)/two-step PHQ-9 (PHQ-2/9), two-item PHQ (PHQ-2), or Kessler Psychological Distress Scale (K-10)—which focused on depression only. Heterogeneity was present across validation studies for all tools in the meta-analyses. Both Deeks’ test and visual assessment of funnel plots did not suggest publication bias for EPDS and PHQ-9/PHQ-2/9.DiscussionPrioritizing the validation of mental health screening tools tailored to adolescents aged 12–18 years is crucial to effectively address the MHDs in SSA. Future research in SSA should focus on adapting and validating existing tools, updating outdated versions, and developing new tools for emerging mental health challenges.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD42023454180.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.